110848 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus B, i.e. influenza B virus Demonstrated effect
MRNA ENCODING INFLUENZA VIRUS-LIKE PARTICLE
#2POLYPEPTIDE FRAGMENTS, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, AND IMPLEMENTATIONS THEREOF
#3NOVEL INFLUENZA ANTIGENS
#4INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF
#5MODIFIED INFLUENZA B HEMAGGLUTININ POLYPEPTIDES AND NUCLEIC ACIDS AND USES THEREOF
#6Influenza virus hemagglutinin proteins and uses thereof
#7Immunogenic compositions against influenza
#8Influenza virus hemagglutinin proteins and uses thereof
#9Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#10INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS
#11Influenza peptides and compositions
#12Influenza virus-like particle production in plants
#13Immunogenic compositions against influenza
#14Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#15Influenza virus hemagglutinin proteins and uses thereof
#16Immunogenic composition
#17Influenza peptides and compositions
#18Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#19Peptide sequences and compositions
#20Peptide sequences and compositions
#21Immunogenic composition
#22Vaccine compositions comprising a saponin adjuvant
#23Immunogenic composition
#24Peptide sequences and compositions
#25ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#26Influenza virus-like particle production in plants
#27Nanoemulsion influenza vaccine
#28MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
#29Compositions and methods for treating influenza
#30Process for manufacturing vaccines
#31Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#32Peptide sequences and compositions
#33Vaccine compositions comprising a saponin adjuvant
#34Deletion mutants of flagellin and methods of use
#35Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof
#36NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#37Process for manufacturing vaccines
#38ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#39Peptide sequences and compositions
#40Nanoemulsion influenza vaccine
#41Immunogenic composition
#42Methods for the propagation of modified influenza viruses in embryonated eggs
#43Immunogenic composition
#44Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#45Immunogenic composition
#46Vaccine Compositions Comprising a Saponin Adjuvant
#47Immunogenic composition
#48Immunogenic composition
#49Compositions that include hemagglutinin
#50Compositions that include hemagglutinin, methods of making and methods of use thereof
#51Methods and interferon deficient substrates for the propagation of viruses